Metraipolis › archive › dc_b5d5acdec45b

The impact of short term Antiretroviral Therapy (ART) interruptions on longer term maternal health outcomes-A randomized clinical trial — Europe PMC PMID:31999753

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/31999753
DOI
10.1371/journal.pone.0228003
License (as archived)
CC0-1.0
Archived
2026-11-09T14:23:58.941Z
SHA-256 of the archived text
c1a453ca6769c3d12e25ec128ea409f8d13e6c34a09f76aa8c9a0fa1363a2109
Stable URL of this page
https://metraipolis.com/documento/dc_b5d5acdec45b

How to cite

The impact of short term Antiretroviral Therapy (ART) interruptions on longer term maternal health outcomes-A randomized clinical trial — Europe PMC PMID:31999753 — Europe PMC (en), https://europepmc.org/article/MED/31999753 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_b5d5acdec45b (Metraipolis archive dc_b5d5acdec45b, sha256 c1a453ca6769c3d12e25ec128ea409f8d13e6c34a09f76aa8c9a0fa1363a2109)
BibTeX
@misc{dcb5d5acdec45b,
  title = {The impact of short term Antiretroviral Therapy (ART) interruptions on longer term maternal health outcomes-A randomized clinical trial — Europe PMC PMID:31999753},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/31999753},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_b5d5acdec45b; sha256 c1a453ca6769c3d12e25ec128ea409f8d13e6c34a09f76aa8c9a0fa1363a2109},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/31999753. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: Given well documented challenges faced by pregnant women living with HIV taking lifetime ART, it is critical to understand the impact of short-term ART exposure followed by treatment interruption on maternal health outcomes. Methods: HIV+ breastfeeding (BF) and Formula Feeding (FF) women with CD4 counts > 350 cells/mm3, enrolled in the 1077BF/1077FF PROMISE trial were followed to assess the effect of ART during pregnancy and breastfeeding respectively. The first analysis compared ART use limited to the antepartum period (AP-only) relative to women randomized to Zidovudine. The second analysis included women with no pregnancy combination ART exposure; and compared women randomized to either ART or no ART during postpartum (PP-only). Both analyses included follow-up time beyond breastfeeding period. The primary outcome was progression to AIDS and/or death. Secondary outcomes included adverse events and HIV-related events. Results: 3490 and 1137 HIV+ women were enrolled from 14 sites in Africa and India from April 2011 through September 2014 in cohort AP-only and PP-only, respectively. Most were Black African (96%); median age was 27 years; 97% were WHO Clinical Stage I; and most had a screening CD4 count ≥500 cells/mm3 (78%). The rate of progression to AIDS and/or death was similar and low across all comparison arms (AP comparison, HR = 1.14, 95%CI (0.44, 2.96), p-value = 0.79). In the PP-only cohort, the rate of WHO stage 2-3 events was lower for women randomized to ART(HR = 0.65, 95% CI 0.42, 1.01, p-value = 0.05). Conclusion: The incidence of AIDS and/or death was low in pregnant/postpartum HIV+ women with highCD4 cell counts for all comparison arms. This provides some reassurance that there were limited consequences for short term ART interruption in this group of asymptomatic HIV+ women during up to 4 years of follow up; and underscores that even short term ART exposure postpartum may reduce the risk of WHO grade 2-3 disease progression.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2020 (prima pubblicazione 2020-01-30).
Identificativi: PMID 31999753 · PMCID PMC6992010 · DOI 10.1371/journal.pone.0228003.
Descrittori MeSH principali: Antiretroviral Therapy, Highly Active; Maternal Health; Outcome Assessment, Health Care.
Pagina: https://europepmc.org/article/MED/31999753 — https://doi.org/10.1371/journal.pone.0228003. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-09T14:19:38.313Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.